Dr. Afshin Eli Gabayan, MD

Expert Publications

• Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma.

Media Releases

Offering a Healing and Supportive Environment with Balanced Cancer Diagnostics and Comprehensive Treatment Options

Beverly Hills, California – Afshin Eli Gabayan, MD, a prominent hematologist-oncologist and the Founder and Medical Director of Beverly Hills Cancer Center, is redefining cancer treatment by integrating state-of-the-art medical care with innovative research. 

At this private, academic facility, patients benefit from a comprehensive range of cancer treatment modalities, all available under one roof. From chemotherapy and radiation therapy to advanced diagnostic imaging and laboratory services, Beverly Hills Cancer Center is a beacon of hope for cancer patients worldwide.

Dr. Gabayan, a 1994 graduate of the prestigious Keck School of Medicine at the University of Southern California, has dedicated his career to advancing cancer treatments. Following his internship and residency at the University of California, Los Angeles (UCLA), where he served as Chief Resident, he honed his expertise in oncology and hematology at Cedars-Sinai Medical Center, where he remained as an attending physician in private practice with expertise in the areas of gastrointestinal, lung, breast cancers and multiple myeloma.

Under Dr. Gabayan’s leadership, Beverly Hills Cancer Center offers patients the unique opportunity to participate in groundbreaking clinical trials that are not widely available. This initiative not only attracts patients from around the globe but also fosters hope through access to the latest advancements in cancer treatment.

At the core of Dr. Gabayan’s practice is a fervent advocacy for advancing medical research for all cancer patients. His dedication to providing the latest therapy options ensures that every patient receives personalized care tailored to their unique needs. This fusion of cutting-edge science and compassionate care has positioned Beverly Hills Cancer Center among the leading cancer treatment facilities in Los Angeles and beyond.

In addition to his medical practice, Dr. Gabayan is deeply committed to his community, regularly delivering lectures on various oncology and hematology topics. His philanthropic efforts, including support for Covenant House, reflect his dedication to making a meaningful impact beyond the walls of the clinic.

Recommended Articles

• Microsoft Co-Founder Paul Allen Beats Lymphoma Twice

  Beating any type of cancer is a major feat in itself, but billionaire and Microsoft co-founder Paul Allen has defeated lymphoma not once, but twice.Paul's storyNeedless to say, being the co-founder of Microsoft is a pretty big deal. As an American digital pioneer, Paul has been on top of the world....

• Little Boy Tugs at Heartstrings of Entire Community: Be the Match!

  Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...

• Can Multiple Myeloma be Asymptomatic?

  Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...

• 9/11 Ground Zero Worker's Lymphoma Improves with Clinical Trial

  When the terrorist attacks occurred in New York on September 11th, 2001, Bart Zagami, a 61-year-old New York State Supreme Court officer, was in his office just a few blocks away from the World Trade Center in lower Manhattan. Days after the 9/11 terrorist attacks, Zagami spent his time at Ground...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

• Tips on How to Live with Multiple Myeloma

  Multiple myeloma, a type of cancer, adversely affects plasma cells, which are your immune system’s components. The American Cancer Society indicates that in 2014, more than 24,000 people in the United States had multiple myeloma.Multiple myeloma patients can lose their appetite due to the adverse...